Transgenomic, a biotechnology company, and Power3 Medical Products, a bio-medical company, have signed a definitive collaboration and exclusive licensing agreement for the rights to Power3 Medical’s neurodegenerative biomarkers.
Reported revenues increased 1% to a record $2.65 billion in the fourth quarter of 2008, against $2.62 billion in the 2007 quarter. The quarterly revenue growth reflects the
Most recently, Edward served as chief operating officer of Kuros BioSurgery. At Roche, as global head of disease management, Edward created the company’s first integrated Pharma-Diagnostic approach for
AdvanDx, a provider of advanced molecular diagnostic products, has received the FDA 510(k) clearance for E coli/P aeruginosa PNA FISH to identify Escherichia coli or Pseudomonas aeruginosa directly
The financing will be used to mature the company’s product pipeline of antibody therapeutics, particularly within the field of oncology. Kirsten Drejer, CEO of Symphogen, said: “The current
The accurate measurement of human epidermal growth factor type 2 (HER2) gene expression can assist physicians with treatment decisions for patients with cancers in tissues such as breast,
Garnet will use the proceeds to fund Phase II clinical trials of its proprietary human adult bone marrow-derived cells, as well as manufacturing and development. Safeguard Scientifics and
Accrual was completed two months ahead of schedule. The company has also announced that PTC124 has been issued the generic name, ataluren. The pivotal trial is ongoing at
Approval was based on two eight-week studies of more than 800 patients that compared twice-daily doses of Vectical ointment with a vehicle treatment. According to the company, the
As a result, the previous licensing agreement between Warner Chilcott and NexMed related to this product has been terminated. Under the terms of the agreement, NexMed received an
Advertise With UsAdvertise on our extensive network of industry websites and newsletters.
Get the PBR newsletterSign up to our free email to get all the latest PBR
news.